Analysis of clinical characteristics of 516 patients with non-Hodgkin's lymphoma in Shanghai area

References

• Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011;58:4–14.
   PubMed Web of Science ®Google Scholar
• Gross SA, Zhu X, Bao L, Ryder J, Le A, Chen Y, et al. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol. 2008;88:165–73.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using REAL, WHO Classifications. Ann Oncol. 2000;11( Suppl 1):S63–7.
   PubMed Web of Science ®Google Scholar
• Yaqo RT, Hughson MD, Sulayvani FK, Al-Allawi NA. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification. Indian J Cancer 2011;48:446–51.
   PubMed Web of Science ®Google Scholar
• Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2005;23:4117–26.
   PubMed Web of Science ®Google Scholar
• Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–30.
   PubMed Web of Science ®Google Scholar
• Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494–502.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang J, Zhang H, Liu D, Li Y, Xu Y. Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma. Eur J Clin Invest. 2012;42:310–20.
   PubMed Web of Science ®Google Scholar
• Bakhoum SF, Danilova OV, Kaur P, Levy NB, Compton DA. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2011;17:7704–11.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Sino-US Leukemia Cooperative Group of Shanghai. Cytogenetic study on 155 cases of non-Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi. 2006;27:656–60.
   PubMedGoogle Scholar
• Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
   Google Scholar
• Mitelman F. An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, TN, October 1994. New York: Karger; 1995.
   Google Scholar
• Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124–30.
   PubMed Web of Science ®Google Scholar
• Lee MY, Tan TD, Feng AC, Liu MC. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. Am J Hematol. 2006;81:568–75.
   PubMed Web of Science ®Google Scholar
• Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011;6:77.
   PubMed Web of Science ®Google Scholar
• Syed S, Khalil S, Pervez S. Anaplastic large cell lymphoma: the most common T-cell lymphoma in Pakistan. Asian Pac J Cancer Prev. 2011;12:685–9.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, et al. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 2008;113:791–8.
   PubMed Web of Science ®Google Scholar
• Cabrera ME, Martinez V, Nathwani BN, Muller-Hermelink HK, Diebold J, Maclennan KA. Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Leuk Lymphoma. 2012;53:1311–7.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Agarwal B, Nathwani BN, Diebold J, McLennan KA, Muller-Hermelink KH. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists. Leuk Lymphoma. 2004;45:1569–77.
   PubMed Web of Science ®Google Scholar
• Shanshal M, Haddad RY. Chronic lymphocytic leukemia. Dis Mon. 2012;58:153–67.
   PubMed Web of Science ®Google Scholar
• Rahemtullah A, Longtine JA, Harris NL, Dorn M, Zembowicz A, Quintanilla-Fend L. CD20+ T-cell lymphoma. Clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol. 2008;32:1593–607.
   PubMed Web of Science ®Google Scholar
• Foukas PG, Kefala M, Papageorgiou S, Tsirigotis P, Panayiotidis P, Korkolopoulou P. CD20 expression in angioimmunoblastic T cell lymphoma. Leuk Lymphoma. 2012;53:345–7.
   PubMed Web of Science ®Google Scholar
• Bo W, Mei K, Zhaoming W, Hongtian Y, Yanfeng B, Xiaoying N. CD79a positive T cell lymphoma with bone marrow involvement. Pathology 2011;43:737–40.
   PubMed Web of Science ®Google Scholar
• Wang E, Stoecker M. Primary mediastinal (thymic) large B cell lymphoma with aberrant expression of CD3: a case report with review of the literature. Int J Hematol. 2010;91:509–15.
   PubMed Web of Science ®Google Scholar
• Noda C, Murata T, Kanda T, Yoshiyama H, Sugimoto A, Kawashima D. Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1. J Biol Chem. 2011;286:42524–33.
   PubMed Web of Science ®Google Scholar
• Chen J, Hu CF, Hou JH, Shao Q, Yan LX, Zhu XF. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma. J Transl Med. 2010;8:30.
   PubMed Web of Science ®Google Scholar
• Paydas S, Ergin M, Erdogan S, Seydaoglu G. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res. 2008;32:1424–30.
   PubMed Web of Science ®Google Scholar
• Strojnik T, Kavalar R, Zajc I, Diamandis EP, Oikonomopoulou K, Lah TT. Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res. 2009;29:3269–79.
   PubMed Web of Science ®Google Scholar
• Conlin PA, Orden MB, Hough TR, Morgan DL. Myeloperoxidase-positive intravascular large B-cell lymphoma. Arch Pathol Lab Med. 2001;125:948–50.
   PubMed Web of Science ®Google Scholar
• Buxton D, Bacchi CE, Gualco G, Weiss LM, Zuppan CW, Rowsell EH. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol. 2009;131:574–9.
   PubMed Web of Science ®Google Scholar
• Lee SP, Park S, Park J, Hong J, Ko YH. Clinicopathologic characteristics of CD99-positive diffuse large B-cell lymphoma. Acta Haematol. 2011;125:167–74.
   PubMed Web of Science ®Google Scholar
• Cox DP, Treseler P, Dong R, Jordan RC. Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:814–9.
   PubMed Web of Science ®Google Scholar
• Benner MF, Jansen PM, Meijer CJ, Willemze R. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol. 2009;161:121–7.
   PubMed Web of Science ®Google Scholar
• Minner S, Kilgué A, Stahl P, Weikert S, Rink M, Dahlem R. Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology 2010;42:356–9.
   PubMed Web of Science ®Google Scholar
• Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol. 2007;20:1055–60.
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Shin ES, Yu ZX, Li SB. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders. Chin Med J. (Engl) 2007;120:2002–5.
   PubMed Web of Science ®Google Scholar
• Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001;122:497–506.
   PubMed Web of Science ®Google Scholar
• Sesti F, Tsitsilonis OE, Kotsinas A, Trougakos IP. Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. In Vivo 2012;26:395–402.
   PubMed Web of Science ®Google Scholar
• Pasanen AK, Kuitunen H, Haapasaari KM, Karihtala P, Kyllönen H, Soini Y. Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas. Leuk Lymphoma. 2012;53:624–31.
   PubMed Web of Science ®Google Scholar
• Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice. Genes Chromosomes Cancer 2005;44:365–72.
   PubMed Web of Science ®Google Scholar
• Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization. Cancer Res. 2006;66:4055–64.
   PubMed Web of Science ®Google Scholar
• Dutrillaux B, Muleris M, Seureau MG. Imbalance of sex chromosomes, with gain of early-replicating X, in human solid tumors. Int J Cancer 1986;38:475–9.
   PubMed Web of Science ®Google Scholar
• Zeidan A, Phatak P. Acquired biclonal chromosome X aberrations without autosomal chromosomal anomalies in acute myeloid leukemia. Cancer Genet Cytogenet. 2008;181:125–30.
   PubMed Web of Science ®Google Scholar
• Kaneko H, Miyazaki M, Nomura K, Horiike S, Taniwaki M, Ohkawara Y. Gastric non-Hodgkin lymphoma in a trisomy X female. Cancer Genet Cytogenet. 2006;170:180–1.
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders M, Bonassi S, Herceg Z, Hirvonen A, Möller L, Phillips DH. Gender-related differences in response to mutagens and carcinogens. Mutagenesis 2010;25:213–21.
   PubMed Web of Science ®Google Scholar
• Agrelo R, Wutz A. Context of change – X inactivation and Disease. EMBO Mol Med. 2010;2:6–15.
   PubMed Web of Science ®Google Scholar
• Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAP-associated factor-1 (XAF1) in cancer cell lines. Genomics 2000;122:15113–22.
   Google Scholar
• Thelander EF, Ichimura K, Corcoran M, Barbany G, Nordgren A, Heyman M. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia. Leuk Lymphoma 2008;49:477–87.
   PubMed Web of Science ®Google Scholar
• McPhail ER, Law ME, Decker PA, O'Neill BP. Influence of 6q22–23 on overall survival in primary central nervous system lymphoma. Analysis of North Central Cancer Treatment Group trials 86 72 52, 93 73 51 and 96 73 51. Br J Haematol. 2011;154:146–50.
   PubMed Web of Science ®Google Scholar
• Qian J, Massion PP. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol. 2008;3:212–5.
   PubMed Web of Science ®Google Scholar
• Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K. Genomic copy number analysisof non-small cell lung cancer using array comparative genomic hybridization:implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2002;62:3636–40.
   PubMed Web of Science ®Google Scholar
• Baohua Y, Xiaoyan Z, Tiecheng Z, Tao Q, Daren S. Mutations of the PIK3CA gene in diffuse large B cell lymphoma. Diagn Mol Pathol. 2008;17:159–65.
   PubMed Web of Science ®Google Scholar
• Chang CM, Schroeder JC, Huang WY, Dunphy CH, Baric RS, Olshan AF. Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res. 2010;34:190–5.
   PubMed Web of Science ®Google Scholar
• Godon A, Moreau A, Talmant P, Baranger-Papot L, Geneviève F, Milpied N. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 2003;17:255–9.
   PubMed Web of Science ®Google Scholar
• Ruminy P, Jardin F, Picquenot JM, Gaulard P, Parmentier F, Buchonnet G. Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology. Oncogene 2006;25:4947–54.
   PubMed Web of Science ®Google Scholar
• Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005;19:652–8.
   PubMed Web of Science ®Google Scholar
• Bernell P, Jacobsson B, Liliemark J, Hjalmar V, Arvidsson I, Hast R. Gain of chromosome 7 marks the progression from indolent to aggressive follicle centre lymphoma and is a common finding in patients with diffuse large B-cell lymphoma: a study by FISH. Br J Haematol. 1998;101:487–91.
   PubMed Web of Science ®Google Scholar
• Chen Q, Lin J, Jinno S, Okayama H.. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 2003;22:992–1001.
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910–6.
   PubMed Web of Science ®Google Scholar
• Wang DM, Miao KR, Fan L, Qiu HR, Fang C, Zhu DX. Intermediate prognosis of 6q deletion in chronic lymphocytic leukemia. Leuk Lymphoma. 2011;52:230–7.
   PubMed Web of Science ®Google Scholar
• Cuneo A, Rigolin GM, Bigoni R, De Angeli C, Veronese A, Cavazzini F. Chronic lymphocytic leukemia with 6q-shows distinct hematological features and intermediate prognosis. Leukemia 2004;18:476–83.
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Bullinger L, Benner A, Wildenberger K, Bentz M, Döhner K. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999;13:1331–4.
   PubMed Web of Science ®Google Scholar
• Crowther-Swanepoel D, Houlston RS. Genetic variation and risk of chronic lymphocytic leukaemia. Semin Cancer Biol. 2010;20:363–9.
   PubMed Web of Science ®Google Scholar
• Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006;20:313–8.
   PubMed Web of Science ®Google Scholar
• Medeiros LJ, Carr J. Overview of the role of molecular methods in the diagnosis of malignantlymphomas. Arch Pathol Lab Med. 1999;123:1189–207.
   PubMed Web of Science ®Google Scholar